Feature

Oncology Protocol Challenge

Are you working on an Early Phase Oncology protocol or study concept? Participate in the Accelovance Oncology Protocol Challenge!

What is the Accelovance Protocol Challenge?

Accelovance's Protocol Challenge is an opportunity for a confidential review and discussion of your protocol or concept document. Our experts will review your information and provide a summary of operational, therapeutic, and strategic considerations tailored to your protocol/study concept. This assessment is free of charge, with no obligation of future work. To learn more, click on the link to download an overview of Accelovance's Protocol Challenge as well as information on how to participate.


News

05/25/2016
Accelovance, Inc. Continues European Expansion with Acquisition of THERAMetrics AG’s CRO Services

05/19/2016
Accelovance Selected to Advance Immunicum’s Oncology Immunotherapy Pipeline

02/11/2016
Accelovance Prepared to Meet Emerging Needs for Zika Virus Research

12/02/2015
Accelovance, Inc. Continues Geographic and Service Expansion with Acquisition of Clinquest, Inc. & BV

11/03/2015
Accelovance, Inc. and FHI 360 Enhance Service Offering Through International Strategic Alliance


Events

American Society of Clinical Oncology (ASCO)
June 3-7, 2016 – Chicago, IL
Booth #6129

Outsourcing in Clinical Trials New England

September 7-8, 2016 – Boston, MA

European Society for Medical Oncology (ESMO) 2016
October 7-11, 2016 – Copenhagen, Denmark

World Vaccine Congress 2016-Europe
October 10-12, 2016 – Barcelona, Spain